Explore By Subject Area   
Return Home
Menu

Lead Podcast

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

Pharma and Drug Delivery executives from Nanoform, Pfizer, GSK, Takeda and Kymanox discuss how they facilitate partnerships between drug product development, device engineering and clinical study teams to determine how to balance concentration and volume and develop optimal devices for delivery and commercialization. 

Read More

Featured Podcasts

Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches

Read More

Directors' Talk PODD 2025 - Keynotes & Key Themes

Read More

Biomaterial Implants to Reduce Patient Burden and Improve Adherence

Read More

Lessons Learned in the Development and Introduction of Closed Loop Systems

Read More

More Related Content

Pharmatalk Radio Podcasts

Sustained Release Innovations to Reduce Patient Burden

Sustained Release Innovations to Reduce Patient Burden
New Approaches to Achieve Targeted Brain Delivery Without Increasing Toxicity

New Approaches to Achieve Targeted Brain Delivery Without Increasing Toxicity
Vaccine Delivery Innovations

Vaccine Delivery Innovations
Advances in Pulmonary Delivery of Biologics

Advances in Pulmonary Delivery of Biologics
Payer Perspectives on Drug Delivery

Payer Perspectives on Drug Delivery
Designing and Developing Drug Delivery for LMICs

Designing and Developing Drug Delivery for LMICs
Antiviral Drug Development: How NanoViricides is Overcoming Challenges to the Current Model

Antiviral Drug Development: How NanoViricides is Overcoming Challenges to the Current Model

Sponsored
Micromachines, Biologic Approaches and New Tools Pushing the Boundaries in Oral Delivery

Micromachines, Biologic Approaches and New Tools Pushing the Boundaries in Oral Delivery
Overcoming Barriers to Adoption of Transdermal Delivery

Overcoming Barriers to Adoption of Transdermal Delivery
Precision Ophthalmic Delivery

Precision Ophthalmic Delivery
Delivery Challenges from the Oncology Pipeline

Delivery Challenges from the Oncology Pipeline
New Approaches in CNS/PNS Delivery

New Approaches in CNS/PNS Delivery
Enhancing Solubility with Novel Excipient Technologies

Enhancing Solubility with Novel Excipient Technologies

Sponsored
The Future of Digital Technology in the Connected Device Space

The Future of Digital Technology in the Connected Device Space
Achieving Targeted Delivery of Gene Editing Therapies

Achieving Targeted Delivery of Gene Editing Therapies
The Promise and Challenges of Ultrasound-Mediated Delivery

The Promise and Challenges of Ultrasound-Mediated Delivery
Novel Nasal Products and Formulations

Novel Nasal Products and Formulations
Keynote Fireside Chat with Dr Robert Langer and Dr Ester Caffarel-Salvador

Keynote Fireside Chat with Dr Robert Langer and Dr Ester Caffarel-Salvador
Current Challenges in Vaccine Delivery and Distribution

Current Challenges in Vaccine Delivery and Distribution
Connected Devices: Providing the Right Level of Value to the Patient that Creates Value Back to the Company

Connected Devices: Providing the Right Level of Value to the Patient that Creates Value Back to the Company
Reflections on Alnylam and Conquering Delivery

Reflections on Alnylam and Conquering Delivery
De-risking Combination Product Development involving Large Volume Subcutaneous Formulations: Key Considerations

De-risking Combination Product Development involving Large Volume Subcutaneous Formulations: Key Considerations
How to Sustain Effective Concentration for a Longer Period with Long Acting Injectables

How to Sustain Effective Concentration for a Longer Period with Long Acting Injectables
Development of the Lipid Nanoparticles that Enabled the Delivery of the Pfizer/BioNTech Covid-19 Vaccine

Development of the Lipid Nanoparticles that Enabled the Delivery of the Pfizer/BioNTech Covid-19 Vaccine
Roche’s Industry Overview on the Drug Delivery Landscape 2022

Roche’s Industry Overview on the Drug Delivery Landscape 2022
Tackling the Increasing Complexity of Manufacturing to Deliver Pipelines

Tackling the Increasing Complexity of Manufacturing to Deliver Pipelines
Long Acting Injectables for Biologics

Long Acting Injectables for Biologics
Utilizing Microgravity to Develop Crystalline Monoclonal Antibodies for Subcutaneous Delivery

Utilizing Microgravity to Develop Crystalline Monoclonal Antibodies for Subcutaneous Delivery
Drug Delivery Pipeline and Technologies, a Year in Review

Drug Delivery Pipeline and Technologies, a Year in Review
Practical Advice for Successful Partnering between Innovator Drug Delivery Companies and Big Pharma

Practical Advice for Successful Partnering between Innovator Drug Delivery Companies and Big Pharma
Nicholas Warne Drug Delivery Industry

Nicholas Warne Drug Delivery Industry
Exploring Ways to Reduce Costs of Developing and Manufacturing Drug Delivery Technologies

Exploring Ways to Reduce Costs of Developing and Manufacturing Drug Delivery Technologies
Making the Leap from IV to Subcutaneous, with Halozyme's ENHANZE® Technology

Making the Leap from IV to Subcutaneous, with Halozyme's ENHANZE® Technology

Sponsored

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.